A pediatric massive transfusion protocol

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 5, 2012, Pages 1273-1277

  Chidester, Sara J ^a   Williams, Nick ^a   Wang, Wei ^b   Groner, Jonathan I ^b,c  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Massive transfusion protocol; Pediatric; Thromboembolic events

Indexed keywords

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; FEMALE; HUMAN; INFORMATION PROCESSING; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MASSIVE TRANSFUSION PROTOCOL; MORBIDITY; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; COHORT STUDIES; FEMALE; HEMORRHAGE; HUMANS; INFANT; INJURY SEVERITY SCORE; MALE; PATIENT SELECTION; TRAUMA CENTERS; TREATMENT OUTCOME; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84869879119     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318265d267     Document Type: Article

References (25)

1. Sperry JL, Ochoa JB, Gunn SR, et al. An FFP:PRBC transfusion ratio 91:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65: 986-993.
2. Duchesne JC, Hunt JP,Wahl G, Marr AB,Wang YZ,Weintraub SE, Wright MJ, McSwain NE Jr. Review of current blood transfusion strategies in a mature Level 1 trauma center: were we wrong for the last 60 years? J Trauma. 2008;65: 272-276; discussion 276-278.
3. Gunter OL, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma. 2008;65: 527-532.
4. Dente CJ, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian Level I Trauma Center. J Trauma. 2009; 66: 1616-1623.
5. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA JR, St Jacques P, Young PP. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma. 2008;64: 1177-1182; discussion 1182-1183.
6. Fraga GP, Bansal V, Coimbra R. Transfusion of blood products in trauma: an update. J Emerg Med. 2010;39: 253-260.
7. Larson CR, White CE, Spinella PC, Jones JA, Holcomb JB, Blackbourne LH, Wade CE. Association of shock, coagulopathy, and initial vital signs with massive transfusion in combat casualties. J Trauma. 2010;69(Suppl 1): S26YS32.
8. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC, Holcomb JB. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma. 2008;64: 1459-1463; discussion 1463-1465.
9. Hoyt DB, Dutton RP, Hauser CJ, et al. Management of coagulopathy in the patients with multiple injuries: results from an international survey of clinical practice. J Trauma. 2008;65: 755-765.
10. McLaughlin DF, Niles SE, Salinas J, Perkins JG, Cox ED, Wade CE, Holcomb JB. A predictive model for massive transfusion in combat casualty. J Trauma. 2008;64(Suppl 2):S57YS63.
11. Cotton BA, Dossett LA, Haut ER, Shafi S, Nunez TC, Au BK, Zaydfudim V, Johnston M, Arbogast P, Young PP. Multicenter validation of a simplified score to predict massive transfusion in trauma. J Trauma. 2010; 69(Suppl 1):S33YS39.
12. Downes K, Sarode R. Massive blood transfusion. Indian J Pediatr. 2001; 68: 145-149.
13. Massive Transfusion Protocol. Nationwide Children's Hospital, General Procedure. 2008.
14. Chang T. Transfusion therapy in critically ill children. Pediatr Neonatol. 2008;49: 5-12.
15. Barret JP, Desai MH, Herndon DN. Massive transfusion of reconstituted whole blood is well tolerated in pediatric burn surgery. J Trauma. 1999; 47: 526-528.
16. Hendrickson JE, Shaz BH, Pereira G, Parker PM, Jessup P, Atwell F, Polstra B, Atkins E, Johnson KK, Bao G, et al. Implementation of a pediatric trauma massive transfusion protocol: one institution's experience. Transfusion. 2012;52: 1228-1236
17. Dressler AM, Finck CM, Carroll CL, Bonanni CC, Spinella PC. Use of a massive transfusion protocol with hemostatic resuscitation for severe intraoperative bleeding in a child. J Pediatr Surg. 2010;45: 1530-1533.
18. Feickert HJ, Schepers AK, Rodeck B, Geerlings H, Hoyer PF. Incidence, impact on survival, and risk factors for multi-organ system failure in children following liver transplantation. Pediatr Transplant. 2001;5: 266-273.
19. Azu MC, McCormack JE, Scriven RJ, Brebbia JS, Shapiro MJ, Lee TK. Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary? J Trauma. 2005;59: 1345-1349.
20. Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma. 2010;68: 52-56.
21. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, et al. CONTROL Study Group. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69: 489-500.
22. Wade CE, Eastridge BJ, Jones JA, West SA, Spinella PC, Perkins JG, Dubick MA, Blackbourne LH, Holcomb JB. Use of recombinant factor VIIa in US military casualties for a five-year period. J Trauma. 2010;69: 353-359.
23. Spinella PC, Perkins JG, McLaughlin DF, Niles SE, Grathwohl KW, Beekley AC, Salinas J, Mehta S, Wade CE, Holcomb JB. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma. 2008;64: 286-293; discussion 293-294.
24. Herbertson M, Kenet G. Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children. Haemophilia. 2008;14: 753-762.
25. Chuansumrit A, Teeraratkul S, Wanichkul S, Treepongkaruna S, Sirachainan N, Pakakasama S, Nuntnarumit P, Hongeng S. rFVIIa Study Group. Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients. Blood Coagul Fibrinolysis. 2010;21: 354-362